Citations (167)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Yarong Zeng, Feihong Zou, Ningshao Xia & Shaowei Li. (2023) In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives. Expert Review of Vaccines 22:1, pages 681-695.
Read now
Read now
Velasco Cimica, Jose M Galarza, Sujatha Rashid & Timothy T. Stedman. (2021) Current development of Zika virus vaccines with special emphasis on virus-like particle technology. Expert Review of Vaccines 20:11, pages 1483-1498.
Read now
Read now
Ludger M. Ickenstein & Patrick Garidel. (2019) Lipid-based nanoparticle formulations for small molecules and RNA drugs. Expert Opinion on Drug Delivery 16:11, pages 1205-1226.
Read now
Read now
Kamel S. Ahmed, Saied A. Hussein, Abdelmoneim H. Ali, Sameh A. Korma, Qiu Lipeng & Chen Jinghua. (2019) Liposome: composition, characterisation, preparation, and recent innovation in clinical applications. Journal of Drug Targeting 27:7, pages 742-761.
Read now
Read now
Hannah G Kelly, Stephen J Kent & Adam K Wheatley. (2019) Immunological basis for enhanced immunity of nanoparticle vaccines. Expert Review of Vaccines 18:3, pages 269-280.
Read now
Read now
Anita Hafner, Jasmina Lovrić, Gorana Perina Lakoš & Ivan Pepić. (2014) Nanotherapeutics in the EU: an overview on current state and future directions. International Journal of Nanomedicine 9, pages 1005-1023.
Read now
Read now
Preeti Garai, Mayuri Gogoi, Ganesh Gopal, Yashwanth Radhakrishnan, Krishnadas Subhadramma Nandakumar & Dipshikha Chakravortty. (2014) The basics and advances of immunomodulators and antigen presentation: a key to development of potent memory response against pathogens. Expert Opinion on Biological Therapy 14:10, pages 1383-1397.
Read now
Read now
Hemat Jain, Vandana Kumavat, Tejinder Singh, Amanda Versteilen & Michal Sarnecki. (2014) Immunogenicity and safety of a pediatric dose of a virosomal hepatitis A vaccine in healthy children in India. Human Vaccines & Immunotherapeutics 10:7, pages 2089-2097.
Read now
Read now
Christian Herzog. (2014) Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature. Expert Review of Vaccines 13:3, pages 399-415.
Read now
Read now
Christian Moser, Matthias Müller, Matthias D Kaeser, Ulrike Weydemann & Mario Amacker. (2013) Influenza virosomes as vaccine adjuvant and carrier system. Expert Review of Vaccines 12:7, pages 779-791.
Read now
Read now
Adele Mount, Sandra Koernig, Anabel Silva, Debbie Drane, Eugene Maraskovsky & Adriana Baz Morelli. (2013) Combination of adjuvants: the future of vaccine design. Expert Review of Vaccines 12:7, pages 733-746.
Read now
Read now
Christian Moser, Mario Amacker & Rinaldo Zurbriggen. (2011) Influenza virosomes as a vaccine adjuvant and carrier system. Expert Review of Vaccines 10:4, pages 437-446.
Read now
Read now
Ali M Harandi, Gwyn Davies & Ole F Olesen. (2009) Vaccine adjuvants: scientific challenges and strategic initiatives. Expert Review of Vaccines 8:3, pages 293-298.
Read now
Read now
Articles from other publishers (154)
Marli Azevedo & Anil K. Patri. 2024. Comprehensive Precision Medicine. Comprehensive Precision Medicine
304
321
.
Meenu Mehta, Thuy Anh Bui, Xinpu Yang, Yagiz Aksoy, Ewa M. Goldys & Wei Deng. (2023) Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development. ACS Materials Au 3:6, pages 600-619.
Crossref
Crossref
Priyanka, Mai Abdel Haleem Abusalah, Hitesh Chopra, Abhilasha Sharma, Suhad Asad Mustafa, Om Prakash Choudhary, Manish Sharma, Manish Dhawan, Rajiv Khosla, Aanchal Loshali, Ankush Sundriyal & Jyoti Saini. (2023) Nanovaccines: A game changing approach in the fight against infectious diseases. Biomedicine & Pharmacotherapy 167, pages 115597.
Crossref
Crossref
Thoa Thi Kim Nguyen, Khang-Yen Pham & Simmyung Yook. (2023) Engineered therapeutic proteins for sustained-release drug delivery systems. Acta Biomaterialia 171, pages 131-154.
Crossref
Crossref
Rocio Mellid-Carballal, Sara Gutierrez-Gutierrez, Carmen Rivas & Marcos Garcia-Fuentes. (2023) Viral protein-based nanoparticles (part 2): Pharmaceutical applications. European Journal of Pharmaceutical Sciences 189, pages 106558.
Crossref
Crossref
Rocio Mellid-Carballal, Sara Gutierrez-Gutierrez, Carmen Rivas & Marcos Garcia-Fuentes. (2023) Viral protein nanoparticles (Part 1): Pharmaceutical characteristics. European Journal of Pharmaceutical Sciences 187, pages 106460.
Crossref
Crossref
Isra Rana, Jaeeun Oh, Juwon Baig, Jeong Hyun Moon, Sejin Son & Jutaek Nam. (2022) Nanocarriers for cancer nano-immunotherapy. Drug Delivery and Translational Research 13:7, pages 1936-1954.
Crossref
Crossref
Annalaura Brai, Federica Poggialini, Claudia Pasqualini, Claudia Immacolata Trivisani, Chiara Vagaggini & Elena Dreassi. (2023) Progress towards Adjuvant Development: Focus on Antiviral Therapy. International Journal of Molecular Sciences 24:11, pages 9225.
Crossref
Crossref
Hasan Ali, Md. Akbar, Babar Iqbal, Faraat Ali, Neeraj Kant Sharma, Nitin Kumar, Asim Najmi, Mohammed Albratty, Hassan A. Alhazmi, Osama A. Madkhali, Khalid Zoghebi & Md Shamsher Alam. (2023) Virosome: An engineered virus for vaccine delivery. Saudi Pharmaceutical Journal 31:5, pages 752-764.
Crossref
Crossref
Hanjin Seo, Leekang Jeon, Jaeyeong Kwon & Hyomin Lee. (2023) High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical Applications. Advanced Healthcare Materials 12:13.
Crossref
Crossref
Muhammad Saad Khan, Sila Appak Baskoy, Celina Yang, Joohye Hong, Jayoung Chae, Heejin Ha, Sungjun Lee, Masayoshi Tanaka, Yonghyun Choi & Jonghoon Choi. (2023) Lipid-based colloidal nanoparticles for applications in targeted vaccine delivery. Nanoscale Advances 5:7, pages 1853-1869.
Crossref
Crossref
Gerrit Koopman, Mario Amacker, Toon Stegmann, Ernst J. Verschoor, Babs E. Verstrepen, Farien Bhoelan, Denzel Bemelman, Kinga P. Böszörményi, Zahra Fagrouch, Gwendoline Kiemenyi-Kayere, Daniella Mortier, Dagmar E. Verel, Henk Niphuis, Roja Fidel Acar, Ivanela Kondova, Yolanda S. Kap, Willy M. J. M. Bogers, Petra Mooij & Sylvain Fleury. (2023) A low dose of RBD and TLR7/8 agonist displayed on influenza virosome particles protects rhesus macaque against SARS-CoV-2 challenge. Scientific Reports 13:1.
Crossref
Crossref
Bharathi Karunakaran, Raghav Gupta, Pranav Patel, Sagar Salave, Amit Sharma, Dhruv Desai, Derajram Benival & Nagavendra Kommineni. (2023) Emerging Trends in Lipid-Based Vaccine Delivery: A Special Focus on Developmental Strategies, Fabrication Methods, and Applications. Vaccines 11:3, pages 661.
Crossref
Crossref
Ayon Chakraborty, Saswati Soumya Mohapatra, Subhashree Barik, Ipsita Roy, Bhavika Gupta & Ashis Biswas. (2023) Impact of nanoparticles on amyloid β-induced Alzheimer’s disease, tuberculosis, leprosy and cancer: a systematic review. Bioscience Reports 43:2.
Crossref
Crossref
Yuanchao Jia, Yuxin Jiang, Yonglong He, Wanting Zhang, Jiahui Zou, Kosheli Thapa Magar, Hamza Boucetta, Chao Teng & Wei He. (2023) Approved Nanomedicine against Diseases. Pharmaceutics 15:3, pages 774.
Crossref
Crossref
Yi Jin, Mhd Anas Tomeh, Peng Zhang, Mingzhu Su, Xiubo Zhao & Zhiqiang Cai. (2023) Microfluidic fabrication of photo-responsive Ansamitocin P-3 loaded liposomes for the treatment of breast cancer. Nanoscale 15:8, pages 3780-3795.
Crossref
Crossref
Ghazala Sultan, Inamul Hasan Madar, Syeda Mahvish Zahra, Mahpara Safdar, Umar Farooq Alahmad, Mahamuda Begum, Ramachandran Chelliah & Deog-Hawn Oh. 2023. Advances in Smart Nanomaterials and their Applications. Advances in Smart Nanomaterials and their Applications
149
174
.
Nick M. Walsh, Heidi M. Soeters, Noele P. Nelson, Yury Khudyakov & Mark K. Weng. 2023. Plotkin's Vaccines. Plotkin's Vaccines
365
388.e15
.
Mohammed Asadullah Jahangir, Dibyalochan Mohanty, Amarendranath Choudhury & Syed Sarim Imam. 2023. Multifunctional And Targeted Theranostic Nanomedicines. Multifunctional And Targeted Theranostic Nanomedicines
49
76
.
Srushti Mahajan, Indrani Maji, Neelesh Kumar Mehra & Pankaj Kumar Singh. 2023. Nanomaterial-Based Drug Delivery Systems. Nanomaterial-Based Drug Delivery Systems
99
145
.
Volkmar Weissig. 2023. Liposomes. Liposomes
1
19
.
Milad Zandi, Fatemeh Hosseini, Ahmad Hosseinzadeh Adli, Shokrollah Salmanzadeh, Emad Behboudi, Peyman Halvaei, Ayda Khosravi & Samaneh Abbasi. (2022) State-of-the-art cerium nanoparticles as promising agents against human viral infections. Biomedicine & Pharmacotherapy 156, pages 113868.
Crossref
Crossref
Yonglong He, Wanting Zhang, Qingqing Xiao, Lifang Fan, Dechun Huang, Wei Chen & Wei He. (2022) Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment. Asian Journal of Pharmaceutical Sciences 17:6, pages 817-837.
Crossref
Crossref
Sofia A. Martins, Joana Santos, Rúben D. M. Silva, Cátia Rosa, Sandra Cabo Verde, João D. G. Correia & Rita Melo. (2022) How promising are HIV-1-based virus-like particles for medical applications. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Mohammad Azharuddin, Geyunjian Harry Zhu, Anirban Sengupta, Jorma Hinkula, Nigel K.H. Slater & Hirak K. Patra. (2022) Nano toolbox in immune modulation and nanovaccines. Trends in Biotechnology 40:10, pages 1195-1212.
Crossref
Crossref
Marcel Franco Mougenot, Vanessa Sousa Pereira, Ana Letícia Rodrigues Costa, Marcelo Lancellotti, Marimelia Aparecida Porcionatto, Juliano Coelho da Silveira & Lucimara Gaziola de la Torre. (2022) Biomimetic Nanovesicles—Sources, Design, Production Methods, and Applications. Pharmaceutics 14:10, pages 2008.
Crossref
Crossref
Sachin Nashik Sanap, Ashwini Kedar, Amol Chhatrapati Bisen, Sristi Agrawal & Rabi Sankar Bhatta. (2022) A recent update on therapeutic potential of vesicular system against fungal keratitis. Journal of Drug Delivery Science and Technology 75, pages 103721.
Crossref
Crossref
Ditipriya Hazra & Amlan Roychowdhury. 2022. Nanomaterials in Clinical Therapeutics. Nanomaterials in Clinical Therapeutics
269
283
.
Elaheh K. Goharshadi, Kimiya Goharshadi & Marjan Moghayedi. (2022) The use of nanotechnology in the fight against viruses: A critical review. Coordination Chemistry Reviews 464, pages 214559.
Crossref
Crossref
Armira Azuar, Harrison Y. R. Madge, Jennifer C. Boer, Jazmina L. Gonzalez Cruz, Jingwen Wang, Zeinab G. Khalil, Cyril Deceneux, Georgia Goodchild, Jieru Yang, Prashamsa Koirala, Waleed M. Hussein, Robert J. Capon, Magdalena Plebanski, Istvan Toth & Mariusz Skwarczynski. (2022) Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A Streptococcus. Vaccines 10:8, pages 1212.
Crossref
Crossref
Xinyu Wang, Yeli Fan, Junjie Yan & Min Yang. (2022) Engineering polyphenol-based polymeric nanoparticles for drug delivery and bioimaging. Chemical Engineering Journal 439, pages 135661.
Crossref
Crossref
Xican Xu, Jin Zhang, Shuang Liu, Chaohui Wang, Hongyu Wang, Huahao Fan, Yigang Tong, Huiyu Liu & Dongsheng Zhou. (2022) New Advances in Nanomaterial‐Based Antiviral Strategies. Small Structures 3:7.
Crossref
Crossref
Alaa A A Aljabali, Kaushik Pal, Rasha M. Bashatwah & Murtaza M. Tambuwala. 2022. Bionanotechnology: Next-Generation Therapeutic Tools. Bionanotechnology: Next-Generation Therapeutic Tools
177
194
.
Alessio Facciolà, Giuseppa Visalli, Antonio Laganà & Angela Di Pietro. (2022) An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives. Vaccines 10:5, pages 819.
Crossref
Crossref
Wade T. Johnson, Nicholas C. Dorn, Dora A. Ogbonna, Nunzio Bottini & Nisarg J. Shah. (2021) Lipid‐based regulators of immunity. Bioengineering & Translational Medicine 7:2.
Crossref
Crossref
Bárbara Fernandes, Rute Castro, Farien Bhoelan, Denzel Bemelman, Ricardo A. Gomes, Júlia Costa, Patrícia Gomes-Alves, Toon Stegmann, Mario Amacker, Paula M. Alves, Sylvain Fleury & António Roldão. (2022) Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate. Pharmaceutics 14:4, pages 854.
Crossref
Crossref
Alexandra Roesch, Sarah Zölls, Daniela Stadler, Constanze Helbig, Klaus Wuchner, Gideon Kersten, Andrea Hawe, Wim Jiskoot & Tim Menzen. (2022) Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and Cells. Journal of Pharmaceutical Sciences 111:4, pages 933-950.
Crossref
Crossref
Reena Singh, Seema Gupta & Pradeep Kumar. (2021) The Role of Nanotechnology in Antiviral Regime: An Overview. Nano LIFE 12:01.
Crossref
Crossref
D. S. Tretiakova & E. L. Vodovozova. (2022) Liposomes as Adjuvants and Vaccine Delivery Systems. Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology 16:1, pages 1-20.
Crossref
Crossref
Jalil Parchekani, Abdollah Allahverdi, Majid Taghdir & Hossein Naderi-Manesh. (2022) Design and simulation of the liposomal model by using a coarse-grained molecular dynamics approach towards drug delivery goals. Scientific Reports 12:1.
Crossref
Crossref
Andreea Milan, Alexandra Mioc, Alexandra Prodea, Marius Mioc, Roxana Buzatu, Roxana Ghiulai, Roxana Racoviceanu, Florina Caruntu & Codruţa Şoica. (2022) The Optimized Delivery of Triterpenes by Liposomal Nanoformulations: Overcoming the Challenges. International Journal of Molecular Sciences 23:3, pages 1140.
Crossref
Crossref
Shalini Iyer, Rajesh Yadav, Smriti Agarwal, Shashank Tripathi & Rachit Agarwal. (2022) Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases. Clinical Microbiology Reviews 35:1.
Crossref
Crossref
Atin Khalaj-Hedayati, Caroline Lin Lin Chua, Peter Smooker & Khai Wooi Lee. 2022. Methods in Recombinant Protein Production. Methods in Recombinant Protein Production
45
89
.
Theodore Sentoukas, Athanasios Skandalis & Stergios Pispas. 2022. Applications of Nanovesicular Drug Delivery. Applications of Nanovesicular Drug Delivery
441
455
.
Yadollah Omidi, Hossein Omidian, Young Kwon & Ana Castejon. 2022. Applications of Nanovesicular Drug Delivery. Applications of Nanovesicular Drug Delivery
167
199
.
Maryam Tabarzad, Elham Mohit & Fatemeh Ghorbani-Bidkorbeh. 2022. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance
425
484
.
Rupal Ojha & Vijay Kumar Prajapati. 2022. System Vaccinology. System Vaccinology
3
16
.
Mahfoozur Rahman, Kainat Alam, Sarwar Beg, Deeksha Chauhan, Vikas Kumar, Abdul Hafeez, Ankit Sahoo, Waleed H. Almalki & Mohammad Javed Ansari. 2022. Nanotherapeutics in Cancer Vaccination and Challenges. Nanotherapeutics in Cancer Vaccination and Challenges
1
12
.
Abhishek Singh & Mukesh Thakur. 2022. Peptide and Peptidomimetic Therapeutics. Peptide and Peptidomimetic Therapeutics
457
471
.
Rushit N. Lodaya, Sonia Gregory, Mansoor M. Amiji & Derek T. O'Hagan. 2022. Practical Aspects of Vaccine Development. Practical Aspects of Vaccine Development
9
25
.
Bassel Akache, Felicity C. Stark, Gerard Agbayani, Tyler M. Renner & Michael J. McCluskie. 2022. Vaccine Design. Vaccine Design
179
231
.
Farrhana Ziana Firdaus, Mariusz Skwarczynski & Istvan Toth. 2022. Vaccine Design. Vaccine Design
145
178
.
Jieru Yang, Armira Azuar, Istvan Toth & Mariusz Skwarczynski. 2022. Vaccine Design. Vaccine Design
295
307
.
Ana Sara Cordeiro, Yogita Patil-Sen, Maitreyi Shivkumar, Ronak Patel, Abdulwahhab Khedr & Mohamed A. Elsawy. (2021) Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application. Pharmaceutics 13:12, pages 2091.
Crossref
Crossref
Eunjung Kim, Eun‐Kyung Lim, Geunseon Park, Chaewon Park, Jong‐Woo Lim, Hyo Lee, Woonsung Na, Minjoo Yeom, Jinyoung Kim, Daesub Song & Seungjoo Haam. (2021) Advanced Nanomaterials for Preparedness Against (Re‐)Emerging Viral Diseases. Advanced Materials 33:47.
Crossref
Crossref
Despo Chatzikleanthous, Derek T. O’Hagan & Roberto Adamo. (2021) Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines. Molecular Pharmaceutics 18:8, pages 2867-2888.
Crossref
Crossref
Raquel Cid & Jorge Bolívar. (2021) Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies. Biomolecules 11:8, pages 1072.
Crossref
Crossref
Khatereh Asadi & Ahmad Gholami. (2021) Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review. International Journal of Biological Macromolecules 182, pages 648-658.
Crossref
Crossref
Sandeep Kumar Singh, Umesh Kumar, Anupam Guleria & Dinesh Kumar. (2021) A brief overview about the use of different bioactive liposome-based drug delivery systems in Peritoneal Dialysis and some other diseases. Nano Express 2:2, pages 022006.
Crossref
Crossref
Maryam Behzadi, Bahareh Vakili, Alireza Ebrahiminezhad & Navid Nezafat. (2021) Iron nanoparticles as novel vaccine adjuvants. European Journal of Pharmaceutical Sciences 159, pages 105718.
Crossref
Crossref
Kailash C. Petkar, Suyash M. Patil, Sandip S. Chavhan, Kan Kaneko, Krutika K. Sawant, Nitesh K. Kunda & Imran Y. Saleem. (2021) An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery. Pharmaceutics 13:4, pages 455.
Crossref
Crossref
N. А. Alpatova, Zh. I. Avdeeva, S. L. Lysikova, O. V. Golovinskaya, L. A. Gayderova & V. P. Bondarev. (2021) General characteristics of adjuvants and their mechanisms of action (part 2). BIOpreparations. Prevention, Diagnosis, Treatment 21:1, pages 20-30.
Crossref
Crossref
Sreedam C. Das, Jason D. Price, Katharine Gosling, Nicola MacLennan, Ricardo Ataíde, Jeffrey Seow, Vashti Irani, Ines I. Atmosukarto, Robin F. Anders, Jack S. Richards, Christopher A. MacRaild & Raymond S. Norton. (2021) Liposome engraftment and antigen combination potentiate the immune response towards conserved epitopes of the malaria vaccine candidate MSP2. Vaccine 39:12, pages 1746-1757.
Crossref
Crossref
Christopher J. Genito, Cole J. Batty, Eric M. Bachelder & Kristy M. Ainslie. (2021) Considerations for Size, Surface Charge, Polymer Degradation, Co‐Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases. Advanced NanoBiomed Research 1:3.
Crossref
Crossref
Vedant Gadekar, Yogeshwari Borade, Suraj Kannaujia, Kuldeep Rajpoot, Neelima Anup, Vishakha Tambe, Kiran Kalia & Rakesh K. Tekade. (2021) Nanomedicines accessible in the market for clinical interventions. Journal of Controlled Release 330, pages 372-397.
Crossref
Crossref
Ankit Kalra & Shilpa Sharma. 2021. Nanopharmaceutical Advanced Delivery Systems. Nanopharmaceutical Advanced Delivery Systems
145
160
.
Razi Ahmad, Sukriti Srivastava, Shubhrima Ghosh & Sunil Kumar Khare. (2021) Phytochemical delivery through nanocarriers: a review. Colloids and Surfaces B: Biointerfaces 197, pages 111389.
Crossref
Crossref
Mallikharjuna Reddy Bogala. 2021. Bio-manufactured Nanomaterials. Bio-manufactured Nanomaterials
279
297
.
Maria João Bebianno, Thiago Lopes Rocha, Jorge Filipe Pontes, André Corrêa Amaral & Ana Grenha. 2021. Nanopharmaceuticals: Principles and Applications Vol. 2. Nanopharmaceuticals: Principles and Applications Vol. 2
289
317
.
Inna Ermilova & Jan Swenson. (2020)
DOPC
versus
DOPE as a helper lipid for gene-therapies: molecular dynamics simulations with DLin-MC3-DMA
. Physical Chemistry Chemical Physics 22:48, pages 28256-28268.
Crossref
Crossref
Zhe Wang, Xingyun Liu, Ying Peng, Meng Su, Saibin Zhu, Jian Pan, Ben Shen, Yanwen Duan & Yong Huang. (2020)
Platensimycin-Encapsulated Liposomes or Micelles as Biosafe Nanoantibiotics Exhibited Strong Antibacterial Activities against Methicillin-Resistant
Staphylococcus aureus
Infection in Mice
. Molecular Pharmaceutics 17:7, pages 2451-2462.
Crossref
Crossref
Sabya Sachi Das, Priyanshu Bharadwaj, Muhammad Bilal, Mahmood Barani, Abbas Rahdar, Pablo Taboada, Simona Bungau & George Z. Kyzas. (2020) Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis. Polymers 12:6, pages 1397.
Crossref
Crossref
Sarwar Beg, Khalid S Alharbi, Nabil K Alruwaili, Nasser Hadal Alotaibi, Waleed H Almalki, Sattam K Alenezi, Waleed M Altowayan, Mohammed S Alshammari & Mahfoozur Rahman. (2020) Nanotherapeutic systems for delivering cancer vaccines: recent advances. Nanomedicine 15:15, pages 1527-1537.
Crossref
Crossref
Ciying Qian, Xinlin Liu, Qin Xu, Zhiping Wang, Jie Chen, Tingting Li, Qingbing Zheng, Hai Yu, Ying Gu, Shaowei Li & Ningshao Xia. (2020) Recent Progress on the Versatility of Virus-Like Particles. Vaccines 8:1, pages 139.
Crossref
Crossref
Zhi-Biao Wang & Jing Xu. (2020) Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant–Antigen Codelivery. Vaccines 8:1, pages 128.
Crossref
Crossref
Florina-Daniela Cojocaru, Doru Botezat, Ioannis Gardikiotis, Cristina-Mariana Uritu, Gianina Dodi, Laura Trandafir, Ciprian Rezus, Elena Rezus, Bogdan-Ionel Tamba & Cosmin-Teodor Mihai. (2020) Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers. Pharmaceutics 12:2, pages 171.
Crossref
Crossref
Filippo Moncalvo, Maria Isabel Martinez Espinoza & Francesco Cellesi. (2020) Nanosized Delivery Systems for Therapeutic Proteins: Clinically Validated Technologies and Advanced Development Strategies. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Crossref
Vijayan, Mohapatra, Uthaman & Park. (2019) Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials. Pharmaceutics 11:10, pages 534.
Crossref
Crossref
A. V. Karaulov, A. S. Bykov & N. V. Volkova. (2019) Review of Grippol Family Vaccine Studies and Modern Adjuvant Development. Epidemiology and Vaccinal Prevention 18:4, pages 101-119.
Crossref
Crossref
Wooseung Lee & Hyung-Jun Im. (2019) Theranostics Based on Liposome: Looking Back and Forward. Nuclear Medicine and Molecular Imaging 53:4, pages 242-246.
Crossref
Crossref
Philip J.M. Brouwer & Rogier W. Sanders. (2019) Presentation of HIV-1 envelope glycoprotein trimers on diverse nanoparticle platforms. Current Opinion in HIV and AIDS 14:4, pages 302-308.
Crossref
Crossref
Rakesh Bastola & Sangkil Lee. (2018) Physicochemical properties of particulate vaccine adjuvants: their pivotal role in modulating immune responses. Journal of Pharmaceutical Investigation 49:3, pages 279-285.
Crossref
Crossref
J Wallis, D P Shenton & R C Carlisle. (2019) Novel approaches for the design, delivery and administration of vaccine technologies. Clinical and Experimental Immunology 196:2, pages 189-204.
Crossref
Crossref
Rabeea Siddique, Yang Liu, Ghulam Nabi, Wasim Sajjad, Mengzhou Xue & Suliman Khan. (2019) Zika Virus Potentiates the Development of Neurological Defects and Microcephaly: Challenges and Control Strategies. Frontiers in Neurology 10.
Crossref
Crossref
Ada Leung, Carolyn Amador, Lin Chuan Wang, Urmi Mody & Marcel Bally. (2019) What Drives Innovation: The Canadian Touch on Liposomal Therapeutics. Pharmaceutics 11:3, pages 124.
Crossref
Crossref
Hua He, Dongfen Yuan, Yun Wu & Yanguang Cao. (2019) Pharmacokinetics and Pharmacodynamics Modeling and Simulation Systems to Support the Development and Regulation of Liposomal Drugs. Pharmaceutics 11:3, pages 110.
Crossref
Crossref
Karina Ovejero Paredes, Jesús Ruiz-Cabello, David Izquierdo Alarcón & Marco Filice. 2019. Nucleic Acid Nanotheranostics. Nucleic Acid Nanotheranostics
421
456
.
Anna-Mari Reid & Namrita Lall. 2019. Medicinal Plants. Medicinal Plants
187
213
.
Alexander Batista-Duharte, Damiana Téllez Martínez & Iracilda Zeppone Carlos. (2018) Efficacy and safety of immunological adjuvants. Where is the cut-off?. Biomedicine & Pharmacotherapy 105, pages 616-624.
Crossref
Crossref
Sin-Yeang Teow, Magdelyn Wong, Hooi-Yeen Yap, Suat-Cheng Peh & Kamyar Shameli. (2018) Bactericidal Properties of Plants-Derived Metal and Metal Oxide Nanoparticles (NPs). Molecules 23:6, pages 1366.
Crossref
Crossref
Zhilin Chen, James J. Moon & Wei Cheng. (2018) Quantitation and Stability of Protein Conjugation on Liposomes for Controlled Density of Surface Epitopes. Bioconjugate Chemistry 29:4, pages 1251-1260.
Crossref
Crossref
Anmol Chandele. (2018) New Technologies for Vaccine Development: Harnessing the Power of Human Immunology. Journal of the Indian Institute of Science 98:1, pages 33-47.
Crossref
Crossref
Parham Sahandi Zangabad, Soroush Mirkiani, Shayan Shahsavari, Behrad Masoudi, Maryam Masroor, Hamid Hamed, Zahra Jafari, Yasamin Davatgaran Taghipour, Hura Hashemi, Mahdi Karimi & Michael R. Hamblin. (2018) Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications. Nanotechnology Reviews 7:1, pages 95-122.
Crossref
Crossref
Francisco M. Averhoff, Yury Khudyakov & Noele P. Nelson. 2018. Plotkin's Vaccines. Plotkin's Vaccines
319
341.e15
.
Deep Pooja, Amrita Kadari, Hitesh Kulhari & Ramakrishna Sistla. 2018. Lipid Nanocarriers for Drug Targeting. Lipid Nanocarriers for Drug Targeting
509
528
.
Reshma J. Nevagi, Istvan Toth & Mariusz Skwarczynski. 2018. Peptide Applications in Biomedicine, Biotechnology and Bioengineering. Peptide Applications in Biomedicine, Biotechnology and Bioengineering
327
358
.
Hong Su, Yafei Wang, Yuanliang Gu, Linda Bowman, Jinshun Zhao & Min Ding. (2018) Potential applications and human biosafety of nanomaterials used in nanomedicine. Journal of Applied Toxicology 38:1, pages 3-24.
Crossref
Crossref
Louise Gourlay, Claudio Peri, Martino Bolognesi & Giorgio Colombo. (2017) Structure and Computation in Immunoreagent Design: From Diagnostics to Vaccines. Trends in Biotechnology 35:12, pages 1208-1220.
Crossref
Crossref
Velasco Cimica & Jose M. Galarza. (2017) Adjuvant formulations for virus-like particle (VLP) based vaccines. Clinical Immunology 183, pages 99-108.
Crossref
Crossref
Danielle D. Barnes, Mimmi L. E. Lundahl, Ed C. Lavelle & Eoin M. Scanlan. (2017)
The Emergence of Phenolic Glycans as Virulence Factors in
Mycobacterium tuberculosis
. ACS Chemical Biology 12:8, pages 1969-1979.
Crossref
Crossref
Sreedam C. Das, Rodrigo A.V. Morales, Jeffrey Seow, Bankala Krishnarjuna, Ravindu Dissanayake, Robin F. Anders, Christopher A. MacRaild & Raymond S. Norton. (2017) Lipid interactions modulate the structural and antigenic properties of the C‐terminal domain of the malaria antigen merozoite surface protein 2. The FEBS Journal 284:16, pages 2649-2662.
Crossref
Crossref
Lavanya Singh, Hendrik G. Kruger, Glenn E.M. Maguire, Thavendran Govender & Raveen Parboosing. (2017) The role of nanotechnology in the treatment of viral infections. Therapeutic Advances in Infectious Disease 4:4, pages 105-131.
Crossref
Crossref
Rebecca A.M. Blom, Mario Amacker, Christian Moser, R. Maarten van Dijk, Raffaela Bonetti, Emilie Seydoux, Sean R.R. Hall, Christophe von Garnier & Fabian Blank. (2017) Virosome-bound antigen enhances DC-dependent specific CD4+ T cell stimulation, inducing a Th1 and Treg profile in vitro. Nanomedicine: Nanotechnology, Biology and Medicine 13:5, pages 1725-1737.
Crossref
Crossref
Rebecca A. M. Blom, Mario Amacker, R. Maarten van Dijk, Christian Moser, Philip A. Stumbles, Fabian Blank & Christophe von Garnier. (2017) Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4+ T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen. Frontiers in Immunology 8.
Crossref
Crossref
Francois Chappuis, Tiziana Farinelli, Henri Deckx, Michal Sarnecki, Oscar Go, Yvonne Salzgeber & Coby Stals. (2017) Immunogenicity and estimation of antibody persistence following vaccination with an inactivated virosomal hepatitis A vaccine in adults: A 20-year follow-up study. Vaccine 35:10, pages 1448-1454.
Crossref
Crossref
Katelyn T. Gause, Adam K. Wheatley, Jiwei Cui, Yan Yan, Stephen J. Kent & Frank Caruso. (2017) Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery. ACS Nano 11:1, pages 54-68.
Crossref
Crossref
H.F. Florindo, J. Lopes, L.C. Silva, M.L. Corvo, M.B. Martins & R. Gaspar. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development
393
410
.
E. Bracho-Sanchez, C.Q. Xia, M.J. Clare-Salzler & B.G. Keselowsky. (2016) Micro and Nano Material Carriers for Immunomodulation. American Journal of Transplantation 16:12, pages 3362-3370.
Crossref
Crossref
Orlando Mayorga, Silja Bühler, Veronika K. Jaeger, Seraina Bally, Christoph Hatz, Gert Frösner, Ulrike Protzer, Pierre Van Damme, Matthias Egger & Christian Herzog. (2016) Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response. Journal of Infectious Diseases 214:10, pages 1498-1506.
Crossref
Crossref
Christopher P. Karch & Peter Burkhard. (2016) Vaccine technologies: From whole organisms to rationally designed protein assemblies. Biochemical Pharmacology 120, pages 1-14.
Crossref
Crossref
Joo Yeon Park, Mi-Gyeong Kim, Gayong Shim & Yu-Kyoung Oh. (2016) Lipid-based antigen delivery systems. Journal of Pharmaceutical Investigation 46:4, pages 295-304.
Crossref
Crossref
Karin L. Lee, Richard M. Twyman, Steven Fiering & Nicole F. Steinmetz. (2016) Virus‐based nanoparticles as platform technologies for modern vaccines. WIREs Nanomedicine and Nanobiotechnology 8:4, pages 554-578.
Crossref
Crossref
Aaron C. Anselmo & Samir Mitragotri. (2016) Nanoparticles in the clinic. Bioengineering & Translational Medicine 1:1, pages 10-29.
Crossref
Crossref
Seo Hee Yoon, Han Wool Kim, Jong Gyun Ahn, In Tae Kim, Jong-Hyun Kim, Kyoung Ae Kong & Kyung-Hyo Kim. (2016) Reappraisal of the Immunogenicity and Safety of Three Hepatitis A Vaccines in Adolescents. Journal of Korean Medical Science 31:1, pages 73.
Crossref
Crossref
Shahad K. Alsaiari, Alaa H. Ezzedine, Abdallah M. Abdallah, Rachid Sougrat & Niveen M. Khashab. (2016) Magnetotactic bacterial cages as safe and smart gene delivery vehicles. OpenNano 1, pages 36-45.
Crossref
Crossref
Matthias GieseMatthias Giese. 2016. Introduction to Molecular Vaccinology. Introduction to Molecular Vaccinology
165
198
.
Yuanzeng Min, Joseph M. Caster, Michael J. Eblan & Andrew Z. Wang. (2015) Clinical Translation of Nanomedicine. Chemical Reviews 115:19, pages 11147-11190.
Crossref
Crossref
Ankita Thakur, Harpreet Kaur & Sukhbir Kaur. (2015) Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice. Immunobiology 220:9, pages 1031-1038.
Crossref
Crossref
Alberta Pasquale, Scott Preiss, Fernanda Silva & Nathalie Garçon. (2015) Vaccine Adjuvants: from 1920 to 2015 and Beyond. Vaccines 3:2, pages 320-343.
Crossref
Crossref
Nishi Mody, Rajeev Sharma, Udita Agrawal & Suresh P Vyas. (2015) Nanocarriers: a versatile approach for mucosal vaccine delivery. Therapeutic Delivery 6:2, pages 231-245.
Crossref
Crossref
Ankita Thakur, Harpreet Kaur & Sukhbir Kaur. (2015) Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis. Parasitology International 64:1, pages 70-78.
Crossref
Crossref
Tom O. McDonald, Marco Siccardi, Darren Moss, Neill Liptrott, Marco Giardiello, Steve Rannard & Andrew Owen. 2015. Nanoengineering. Nanoengineering
173
223
.
Barbara Sanders, Martin Koldijk & Hanneke Schuitemaker. 2015. Vaccine Analysis: Strategies, Principles, and Control. Vaccine Analysis: Strategies, Principles, and Control
45
80
.
Ruchi R Shah, Derek T O'Hagan, Mansoor M Amiji & Luis A Brito. (2014) The impact of size on particulate vaccine adjuvants. Nanomedicine 9:17, pages 2671-2681.
Crossref
Crossref
Luis A. Brito & Derek T. O'Hagan. (2014) Designing and building the next generation of improved vaccine adjuvants. Journal of Controlled Release 190, pages 563-579.
Crossref
Crossref
Asghar Abdoli, Hoorieh Soleimanjahi, Masoumeh Tavassoti Kheiri, Abbas Jamali, Vahideh Mazaheri & Meghdad Abdollahpour Alitappeh. (2014) An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice. Pathogens and Disease, pages n/a-n/a.
Crossref
Crossref
Sang Hyoung Park, Suk-Kyun Yang, Soo-Kyung Park, Jong Wook Kim, Dong-Hoon Yang, Kee Wook Jung, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung & Jin-Ho Kim. (2014) Efficacy of Hepatitis A Vaccination and Factors Impacting on Seroconversion in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:1, pages 69-74.
Crossref
Crossref
Jaroslav Turánek, Josef Mašek, Michal Křupka & Milan Raška. 2014. Molecular Vaccines. Molecular Vaccines
561
577
.
Daniel Shouval. 2014. Viral Infections of Humans. Viral Infections of Humans
417
438
.
Sara BrennerEllis Tobin. 2013. The Clinical Nanomedicine Handbook. The Clinical Nanomedicine Handbook
1
84
.
Pankaj Ranjan Karn, Wonkyung Cho & Sung-Joo Hwang. (2013) Liposomal drug products and recent advances in the synthesis of supercritical fluid-mediated liposomes. Nanomedicine 8:9, pages 1529-1548.
Crossref
Crossref
Odile Launay. (2013) Vaccination of Immunocompromised Travelers: Need for Specific Recommendations!. Journal of Travel Medicine 20:5, pages 275-277.
Crossref
Crossref
Gaëlle Vacher, Matthias D. Kaeser, Christian Moser, Robert Gurny & Gerrit Borchard. (2013) Recent Advances in Mucosal Immunization Using Virus-like Particles. Molecular Pharmaceutics 10:5, pages 1596-1609.
Crossref
Crossref
Yuchen Fan & Qiang Zhang. (2013) Development of liposomal formulations: From concept to clinical investigations. Asian Journal of Pharmaceutical Sciences 8:2, pages 81-87.
Crossref
Crossref
Catherine A Schütz, Lucienne Juillerat-Jeanneret, Heinz Mueller, Iseult Lynch & Michael Riediker. (2013) Therapeutic nanoparticles in clinics and under clinical evaluation. Nanomedicine 8:3, pages 449-467.
Crossref
Crossref
Gopalakrishna Pillai & Maria L Ceballos-Coronel. (2013) Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists. SAGE Open Medicine 1, pages 205031211351375.
Crossref
Crossref
Ali Badiee, Vahid Heravi Shargh, Ali Khamesipour & Mahmoud Reza Jaafari. (2013) Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends. Vaccine 31:5, pages 735-749.
Crossref
Crossref
Trudy V. Murphy, Stephen M. Feinstone & Beth P. Bell. 2013. Vaccines. Vaccines
183
204
.
Jessica Kalra & Marcel B. Bally. 2013. Fundamentals of Pharmaceutical Nanoscience. Fundamentals of Pharmaceutical Nanoscience
27
63
.
Christian Moser & Mario Amacker. 2013. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines
287
307
.
Flavia De Bernardis, Mario Amacker, Silvia Arancia, Silvia Sandini, Christel Gremion, Rinaldo Zurbriggen, Christian Moser & Antonio Cassone. (2012) A virosomal vaccine against candidal vaginitis: Immunogenicity, efficacy and safety profile in animal models. Vaccine 30:30, pages 4490-4498.
Crossref
Crossref
Amirul I. Mallick, Raveendra R. Kulkarni, Michael St. Paul, Payvand Parvizi, Éva Nagy, Shahriar Behboudi & Shayan Sharif. (2012) Vaccination with CpG-Adjuvanted Avian Influenza Virosomes Promotes Antiviral Immune Responses and Reduces Virus Shedding in Chickens. Viral Immunology, pages 120418071632002.
Crossref
Crossref
Sean M. Geary, Caitlin D. Lemke, Yogita Krishnamachari & Aliasger K. Salem. 2012. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology
391
421
.
Douglas S. Watson, Aaron N. Endsley & Leaf Huang. (2012) Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. Vaccine 30:13, pages 2256-2272.
Crossref
Crossref
Rino Rappuoli & Ennio De GregorioChristian Moser. 2011. Novel Immunologic Adjuvants. Novel Immunologic Adjuvants
42
53
.
Aiala Salvador, Manoli Igartua, Rosa Maria Hernández & José Luis Pedraz. (2011) An Overview on the Field of Micro- and Nanotechnologies for Synthetic Peptide-Based Vaccines. Journal of Drug Delivery 2011, pages 1-18.
Crossref
Crossref
Christoph Hatz, Robert van der Ploeg, Bernhard R. Beck, Gert Frösner, Marjory Hunt & Christian Herzog. (2011) Successful Memory Response following a Booster Dose with a Virosome-Formulated Hepatitis A Vaccine Delayed Up to 11 Years. Clinical and Vaccine Immunology 18:5, pages 885-887.
Crossref
Crossref
Amirul Islam Mallick, Payvand Parvizi, Leah R. Read, Éva Nagy, Shahriar Behboudi & Shayan Sharif. (2011) Enhancement of immunogenicity of a virosome-based avian influenza vaccine in chickens by incorporating CpG-ODN. Vaccine 29:8, pages 1657-1665.
Crossref
Crossref
Erin F. Nicholls, Laurence Madera & Robert E. W. Hancock. (2010) Immunomodulators as adjuvants for vaccines and antimicrobial therapy. Annals of the New York Academy of Sciences 1213:1, pages 46-61.
Crossref
Crossref
Carolyn Driver. (2010) Criteria for choosing hepatitis A vaccine. Practice Nursing 21:9, pages 479-482.
Crossref
Crossref
Geert Leroux-Roels. (2010) Unmet needs in modern vaccinology. Vaccine 28, pages C25-C36.
Crossref
Crossref
Ursula Wiedermann, C. Wiltschke, J. Jasinska, M. Kundi, R. Zurbriggen, E. Garner-Spitzer, R. Bartsch, G. Steger, H. Pehamberger, O. Scheiner & C. C. Zielinski. (2009) A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study. Breast Cancer Research and Treatment 119:3, pages 673-683.
Crossref
Crossref
Syed M. Faisal, WeiWei Yan, Sean P. McDonough, Hussni O. Mohammed, Thomas J. Divers & Yung-Fu Chang. (2009) Immune response and prophylactic efficacy of smegmosomes in a hamster model of leptospirosis. Vaccine 27:44, pages 6129-6136.
Crossref
Crossref
L. Salleras. (2009) Vacunación universal frente a la hepatitis A. Vacunas 10:1, pages 1-3.
Crossref
Crossref